China Endocrinology Drugs Market Research Report 2018

March 2018 | 97 pages | ID: C4DE49B369CEN
QYResearch

Abstracts

The global Endocrinology Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Endocrinology Drugs development status and future trend in China, focuses on top players in China, also splits Endocrinology Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Novo Nordisk
• Sanofi
• Merck
• Eli Lily
• AstraZeneca
• AbbVie
• GSK
• Bayer
• Astellas Pharma

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Thyroid hormone disorder drugs
• Diabetes drugs
• Human growth hormone
• Testosterone replacement therapy

On the basis of the end users/application, this report covers

• Drugstore
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Endocrinology Drugs Market Research Report 2018

1 ENDOCRINOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Endocrinology Drugs
1.2 Classification of Endocrinology Drugs by Product Category
  1.2.1 China Endocrinology Drugs Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Endocrinology Drugs Sales (K Units) Market Share by Type in 2017
  1.2.3 Thyroid hormone disorder drugs
  1.2.4 Diabetes drugs
  1.2.5 Human growth hormone
  1.2.6 Testosterone replacement therapy
1.3 China Endocrinology Drugs Market by Application/End Users
  1.3.1 China Endocrinology Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 China Endocrinology Drugs Market by Region
  1.4.1 China Endocrinology Drugs Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Endocrinology Drugs Status and Prospect (2013-2025)
  1.4.3 East China Endocrinology Drugs Status and Prospect (2013-2025)
  1.4.4 Southwest China Endocrinology Drugs Status and Prospect (2013-2025)
  1.4.5 Northeast China Endocrinology Drugs Status and Prospect (2013-2025)
  1.4.6 North China Endocrinology Drugs Status and Prospect (2013-2025)
  1.4.7 Central China Endocrinology Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Endocrinology Drugs (2013-2025)
  1.5.1 China Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Endocrinology Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA ENDOCRINOLOGY DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Endocrinology Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Endocrinology Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Endocrinology Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Endocrinology Drugs Market Competitive Situation and Trends
  2.4.1 China Endocrinology Drugs Market Concentration Rate
  2.4.2 China Endocrinology Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Endocrinology Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA ENDOCRINOLOGY DRUGS SALES AND REVENUE BY REGION (2013-2018)

3.1 China Endocrinology Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Endocrinology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Endocrinology Drugs Price (USD/Unit) by Regions (2013-2018)

4 CHINA ENDOCRINOLOGY DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Endocrinology Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Endocrinology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Endocrinology Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Endocrinology Drugs Sales Growth Rate (%) by Type (2013-2018)

5 CHINA ENDOCRINOLOGY DRUGS SALES BY APPLICATION (2013-2018)

5.1 China Endocrinology Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Endocrinology Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA ENDOCRINOLOGY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Endocrinology Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Endocrinology Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Endocrinology Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Eli Lily
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Endocrinology Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lily Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Endocrinology Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Endocrinology Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 GSK
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Endocrinology Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GSK Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Endocrinology Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Astellas Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Endocrinology Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astellas Pharma Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview

7 ENDOCRINOLOGY DRUGS MANUFACTURING COST ANALYSIS

7.1 Endocrinology Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endocrinology Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Endocrinology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endocrinology Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA ENDOCRINOLOGY DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Endocrinology Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Endocrinology Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Endocrinology Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Endocrinology Drugs Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Endocrinology Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Endocrinology Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Endocrinology Drugs
Table China Endocrinology Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Endocrinology Drugs Sales Volume Market Share by Types in 2017
Figure Thyroid hormone disorder drugs Product Picture
Figure Diabetes drugs Product Picture
Figure Human growth hormone Product Picture
Figure Testosterone replacement therapy Product Picture
Figure China Endocrinology Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Endocrinology Drugs by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Endocrinology Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Endocrinology Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Endocrinology Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Endocrinology Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Endocrinology Drugs Sales Share (%) by Players/Manufacturers
Table China Endocrinology Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Endocrinology Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Endocrinology Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Endocrinology Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Endocrinology Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Endocrinology Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Endocrinology Drugs Market Share of Top 3 Players/Manufacturers
Figure China Endocrinology Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Endocrinology Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Endocrinology Drugs Product Category
Table China Endocrinology Drugs Sales (K Units) by Regions (2013-2018)
Table China Endocrinology Drugs Sales Share (%) by Regions (2013-2018)
Figure China Endocrinology Drugs Sales Share (%) by Regions (2013-2018)
Figure China Endocrinology Drugs Sales Market Share (%) by Regions in 2017
Table China Endocrinology Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Endocrinology Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Endocrinology Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Endocrinology Drugs Revenue Market Share (%) by Regions in 2017
Table China Endocrinology Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Endocrinology Drugs Sales (K Units) by Type (2013-2018)
Table China Endocrinology Drugs Sales Share (%) by Type (2013-2018)
Figure China Endocrinology Drugs Sales Share (%) by Type (2013-2018)
Figure China Endocrinology Drugs Sales Market Share (%) by Type in 2017
Table China Endocrinology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Endocrinology Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Endocrinology Drugs by Type (2013-2018)
Figure Revenue Market Share of Endocrinology Drugs by Type in 2017
Table China Endocrinology Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Endocrinology Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Endocrinology Drugs Sales (K Units) by Applications (2013-2018)
Table China Endocrinology Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Endocrinology Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Endocrinology Drugs Sales Market Share (%) by Application in 2017
Table China Endocrinology Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Endocrinology Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Novo Nordisk Endocrinology Drugs Basic Information List
Table Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novo Nordisk Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novo Nordisk Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Novo Nordisk Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Sanofi Endocrinology Drugs Basic Information List
Table Sanofi Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Sanofi Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Merck Endocrinology Drugs Basic Information List
Table Merck Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Merck Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Merck Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Eli Lily Endocrinology Drugs Basic Information List
Table Eli Lily Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eli Lily Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eli Lily Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Eli Lily Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table AstraZeneca Endocrinology Drugs Basic Information List
Table AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure AstraZeneca Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table AbbVie Endocrinology Drugs Basic Information List
Table AbbVie Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AbbVie Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AbbVie Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure AbbVie Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table GSK Endocrinology Drugs Basic Information List
Table GSK Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GSK Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GSK Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure GSK Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Bayer Endocrinology Drugs Basic Information List
Table Bayer Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bayer Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bayer Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Bayer Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Astellas Pharma Endocrinology Drugs Basic Information List
Table Astellas Pharma Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Astellas Pharma Endocrinology Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Astellas Pharma Endocrinology Drugs Sales Market Share (%) in China (2013-2018)
Figure Astellas Pharma Endocrinology Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endocrinology Drugs
Figure Manufacturing Process Analysis of Endocrinology Drugs
Figure Endocrinology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Endocrinology Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Endocrinology Drugs
Table Distributors/Traders List
Figure China Endocrinology Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Endocrinology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Endocrinology Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Endocrinology Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Endocrinology Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Endocrinology Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Endocrinology Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Endocrinology Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Endocrinology Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Endocrinology Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Endocrinology Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Endocrinology Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Endocrinology Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources